ProQR Therapeutics (PRQR) EBIT Growth (3y) (2016 - 2026)
ProQR Therapeutics (PRQR) EBIT Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 38.78% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | -13.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.28% |
| Dec 31, 2025 | 9.95% |
| Sep 30, 2025 | 17.12% |
| Jun 30, 2025 | 8.20% |
| Mar 31, 2025 | 14.07% |
| Dec 31, 2024 | 16.52% |
| Sep 30, 2024 | 15.72% |
| Jun 30, 2024 | 35.15% |
| Mar 31, 2024 | 12.62% |
| Dec 31, 2023 | 18.71% |
| Sep 30, 2023 | 12.04% |
| Jun 30, 2023 | -37.91% |
| Mar 31, 2023 | 17.10% |
| Dec 31, 2022 | 10.58% |
| Sep 30, 2022 | -13.81% |
| Jun 30, 2022 | -10.18% |
| Mar 31, 2022 | -4.96% |
| Dec 31, 2021 | -10.48% |
| Sep 30, 2021 | -24.71% |
| Jun 30, 2021 | -1.83% |